Skip to content

CUMBERLAND PHARMACEUTICALS INC

CPIX

CIK 0001087294

← back to feed
Revenue (TTM)
$39.97M
+65.0% YoY Q1 May 2026
Net Income (TTM)
−$4.71M
+27.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.32
+30.8% YoY Q1 May 2026
Gross Margin
84.1%
Q1 May 2026
Operating Margin
-11.4%
Q1 May 2026
Net Margin
-11.8%
Q1 May 2026
Free Cash Flow (TTM)
$534.18K
Q1 May 2026
Cash
$11.01M
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
14.98M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings